<DOC>
	<DOCNO>NCT01510535</DOCNO>
	<brief_summary>The purpose study compare efficacy safety intra-articular LBSA0103 versus intra-articular hyaluronic acid injection ( Hyruan Plus Injection ) weekly 3 week treatment patient osteoarthritis knee .</brief_summary>
	<brief_title>Efficacy Safety LBSA0103 Versus Hyruan Plus Injection Patients With Knee Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Over 40 year age Kellgren &amp; Lawrence grade IIII If one knee weight bear pain least 40mm evaluate 100mm VAS Be willing discontinue nonsteroidal antiinflammatory drug ( NSAIDs ) , analgesic , condroichin sulfate/glucosamine physical therapy duration study Body mass index &gt; 32 Have rheumarthritis Patients weightbearing pain le 40mm knee measure 100mmVAS Have Sudek 's atrophy , Paget 's disease , Spinal disc herniation Kellgren &amp; Lawrence Grade IV</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Osteoartritis</keyword>
	<keyword>Knee</keyword>
	<keyword>LBSA0103</keyword>
	<keyword>Hyruan Plus Inj .</keyword>
</DOC>